Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians
-
Published:2024-08
Issue:8
Volume:24
Page:512-522
-
ISSN:2152-2650
-
Container-title:Clinical Lymphoma Myeloma and Leukemia
-
language:en
-
Short-container-title:Clinical Lymphoma Myeloma and Leukemia
Author:
Kuykendall Andrew T.ORCID,
Fine Jennifer T.,
Kremyanskaya Marina
Funder
Protagonist Therapeutics
Reference87 articles.
1. International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data;Arber;Blood,2022
2. How common are myeloproliferative neoplasms? A systematic review and meta-analysis;Titmarsh;Am J Hematol,2014
3. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union;Moulard;Eur J Haematol,2014
4. Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011;Deadmond;J Cancer Res Clin Oncol,2015
5. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia;Ann Intern Med,1995